4/A
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-19-023074
Options or other derivatives
- Chief Scientific Officer acquired 11,485 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ettenberg Seth Chief Scientific Officer | 2019-03-25 | Option exercise · Stock Option (Right to Buy) | −11,485 | 329,145 | D | ||
Loading xslF345X03/doc4a.xml…